Schiff Hardin advised Good Works II Acquisition Corp. on the deal. Good Works II Acquisition Corp. announced its initial public offering of 23,000,000 units, which included the...
You must be a Standard 1 Year member to access this content.
Schiff Hardin advised the underwriter on the deal. Unicycive Therapeutics (NASDAQ:UNCY) has priced its IPO of 5M units at $5.00/unit, for expected gross proceeds are $25M....
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP advised FT Global Capital on the deal. Senmiao Technology Limited (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry in...
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP advised the placement agent on the deal. Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), a leading high-performance computing solutions provider, announced it...
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP advised Esports Technologies, Inc. on the deal. Esports Technologies, Inc. (Nasdaq: EBET), a global provider of advanced electronic sports (or esports) wagering products...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Cipher Mining Technologies on the deal while Schiff Hardin represented Good Works Acquisition Corp. Cipher Mining Technologies Inc., a newly formed U.S.-based...
You must be a Standard 1 Year member to access this content.
Schiff Hardin LLP advised CNS Pharmaceuticals, Inc. on the deal. CNS Pharmaceuticals, Inc. announced its public offering of 5,750,000 shares of common stock and 2,875,000 warrants to...
You must be a Standard 1 Year member to access this content.
